Compare Amylx Pharmaceuticals Inc (AMLX) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Monolithic Power Systems Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Monolithic Power Systems Inc trades at $1,450.35 (market cap $68.90B). The key difference: Monolithic Power Systems Inc is far larger — about 26.1× Amylx Pharmaceuticals Inc's market cap, and Monolithic Power Systems Inc pays a 0.57% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | MPWR | |
|---|---|---|
Market Cap | $2.64B | $68.90B |
Sector | Health | Utilities |
52-Week High | $24.19 | $1.69K |
52-Week Low | $7.82 | $820.74 |
Enterprise Value | $2.39B | $67.51B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
